众生药业：公司正在积极推进RAY1225注射液治疗肥胖/超重患者与2型糖尿病患者的III期临床试验

Group 1 - The company is actively advancing the Phase III clinical trial of its innovative drug RAY1225, which is aimed at treating obesity/overweight patients and those with type 2 diabetes [2] - The company aims to complete the relevant research and apply for drug approval as soon as possible to provide more treatment options for patients [2]